Calendar

pharmadog

Week of Oct 17, 2022

Oct 21, 2022approval1391d agoRINVOQ (UPADACITINIB) — FDA approvalupadacitinib tartrate ER

Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →upadacitinib tartrate ER →fda approvals ↗

Week of Oct 24, 2022

Oct 24, 2022approval1388d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

Oct 24, 2022approval1388d agoIGALMI (DEXMEDETOMIDINE HYDROCHLORIDE) — FDA approvaldexmedetomidine

Sponsor: BIOXCEL. Form: FILM. Route: BUCCAL, SUBLINGUAL

full page →dexmedetomidine →fda approvals ↗

Oct 24, 2022approval1388d agoVEKLURY (REMDESIVIR) — FDA approvalremdesivir

Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: INTRAVENOUS

full page →remdesivir →fda approvals ↗

Oct 25, 2022approval1387d agoVIGABATRIN — FDA approvalVIGABATRIN

Sponsor: GRANULES. Form: FOR SOLUTION. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

Oct 25, 2022approval1387d agoTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalteclistamab

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →teclistamab →fda approvals ↗

Oct 25, 2022approval1387d agoATORVASTATIN CALCIUM — FDA approvalSciegen Pharmaceuticals Inc

Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 26, 2022approval1386d agoVIGABATRIN — FDA approvalPyros Pharmaceuticals Inc.

Sponsor: ALKEM LABS LTD. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Oct 26, 2022approval1386d agoEPRONTIA (TOPIRAMATE) — FDA approvaltopiramate ER

Sponsor: AZURITY. Form: SOLUTION. Route: ORAL

full page →topiramate ER →fda approvals ↗

Oct 27, 2022approval1385d agoVIGABATRIN — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 27, 2022approval1385d agoVIGABATRIN — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Oct 28, 2022approval1384d agoVIGABATRIN — FDA approvalInvaGen Pharmaceuticals Inc

Sponsor: INVAGEN PHARMS. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Oct 28, 2022approval1384d agoVIGABATRIN — FDA approvalInvaGen Pharmaceuticals Inc

Sponsor: INVAGEN PHARMS. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Oct 28, 2022approval1384d agoXYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) — FDA approvalSanofi

Sponsor: CHATTEM SANOFI. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗

Oct 28, 2022approval1384d agoPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalenfortumab vedotin

Sponsor: ASTELLAS. Form: INJECTABLE. Route: INJECTION

full page →enfortumab vedotin →fda approvals ↗

Oct 28, 2022approval1384d agoLEUPROLIDE ACETATE — FDA approvalLEUPROLIDE ACETATE

Sponsor: AMNEAL. Form: SOLUTION. Route: SUBCUTANEOUS

full page →LEUPROLIDE ACETATE →fda approvals ↗

Week of Oct 31, 2022

Nov 1, 2022approval1380d agoDATSCAN (IOFLUPANE I-123) — FDA approval

Sponsor: GE HLTHCARE INC. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Nov 1, 2022approval

Week of Nov 7, 2022

Nov 8, 2022approval1373d agoVIGABATRIN — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Nov 8, 2022approval

Week of Nov 14, 2022

Nov 15, 2022approval1366d agoBUDESONIDE — FDA approvalbudesonide DR

Sponsor: RISING. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

full page →budesonide DR →fda approvals ↗

Nov 15, 2022approval

Week of Nov 21, 2022

Nov 21, 2022approval1360d agoVERQUVO (VERICIGUAT) — FDA approvalMerck & Co., Inc.

Sponsor: MSD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 22, 2022approval

← prev

page 4 of 509

Week of Oct 17, 2022

Week of Oct 24, 2022

Week of Oct 31, 2022

Week of Nov 7, 2022

Week of Nov 14, 2022

Week of Nov 21, 2022